Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer's disease

被引:12
|
作者
Franzmeier, Nicolai [1 ,2 ,3 ,4 ]
Dehsarvi, Amir [1 ]
Steward, Anna [1 ]
Biel, Davina [1 ]
Dewenter, Anna [1 ]
Roemer, Sebastian Niclas [1 ]
Wagner, Fabian [1 ]
Gross, Mattes [1 ,5 ]
Brendel, Matthias [2 ,5 ]
Moscoso, Alexis [3 ,4 ]
Arunachalam, Prithvi [3 ,4 ]
Blennow, Kaj [3 ,4 ,6 ]
Zetterberg, Henrik [3 ,4 ,6 ,7 ,8 ,9 ,10 ]
Ewers, Michael [1 ,11 ]
Schoell, Michael [3 ,4 ,12 ,13 ]
机构
[1] Ludwig Maximilians Univ Munchen, Univ Hosp, Inst Stroke & Dementia Res ISD, Munich, Germany
[2] Munich Cluster Syst Neurol SyNergy, Munich, Germany
[3] Univ Gothenburg, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Sahlgrenska Acad, Molndal, Sweden
[4] Univ Gothenburg, Inst Neurosci & Physiol, Sahlgrenska Acad, Dept Psychiat & Neurochem, Gothenburg, Sweden
[5] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Nucl Med, Munich, Germany
[6] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden
[7] UCL Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London, England
[8] UCL, UK Dementia Res Inst, London, England
[9] Hong Kong Ctr Neurodegenerat Dis, Clear Water Bay, Hong Kong, Peoples R China
[10] Univ Wisconsin, Wisconsin Alzheimers Dis Res Ctr, Sch Med & Publ Hlth, Madison, WI USA
[11] German Ctr Neurodegenerat Dis DZNE, Munich, Germany
[12] Univ Gothenburg, Wallenberg Ctr Mol & Translat Med, Gothenburg, Sweden
[13] UCL, Queen Sq Inst Neurol, Dementia Res Ctr, London, England
基金
瑞典研究理事会; 欧盟地平线“2020”;
关键词
MESSENGER-RNA; MOUSE MODEL; HYPERACTIVITY; ANTIBODIES; RELEASE; NEURONS; BETA;
D O I
10.1038/s41467-023-44374-w
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
In Alzheimer's disease, amyloid-beta (A beta) triggers the trans-synaptic spread of tau pathology, and aberrant synaptic activity has been shown to promote tau spreading. A beta induces aberrant synaptic activity, manifesting in increases in the presynaptic growth-associated protein 43 (GAP-43), which is closely involved in synaptic activity and plasticity. We therefore tested whether A beta-related GAP-43 increases, as a marker of synaptic changes, drive tau spreading in 93 patients across the aging and Alzheimer's spectrum with available CSF GAP-43, amyloid-PET and longitudinal tau-PET assessments. We found that (1) higher GAP-43 was associated with faster A beta-related tau accumulation, specifically in brain regions connected closest to subject-specific tau epicenters and (2) that higher GAP-43 strengthened the association between A beta and connectivity-associated tau spread. This suggests that GAP-43-related synaptic changes are linked to faster A beta-related tau spread across connected regions and that synapses could be key targets for preventing tau spreading in Alzheimer's disease. Trans-synaptic tau spread drives neurodegeneration in Alzheimer's disease. This study shows that GAP-43, a marker of synaptic abnormality, is linked to faster tau spread, showing that synaptic changes may contribute to tau spreading in Alzheimer's disease.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Comparison of Amyloid β and Tau Spread Models in Alzheimer's Disease
    Kim, Hang-Rai
    Lee, Peter
    Seo, Sang Won
    Roh, Jee Hoon
    Oh, Minyoung
    Oh, Jungsu S.
    Oh, Seung Jun
    Kim, Jae Seung
    Jeong, Yong
    CEREBRAL CORTEX, 2019, 29 (10) : 4291 - 4302
  • [32] Verbal Fluency associated with tau accumulation and not amyloid deposition in the Alzheimer's disease spectrum
    Rahmouni, Nesrine
    Stevenson, Alyssa
    Stevenson, Jenna
    Tissot, Cecile
    Lussier, Firoza Z.
    Bezgin, Gleb
    Therriault, Joseph
    Chamoun, Mira
    Poltronetti, Nina M.
    Pallen, Vanessa
    Kang, Min-Su
    Pascoal, Tharick A.
    Vitali, Paolo
    Benedet, Andrea L.
    Rosa-Neto, Pedro
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2021, 41 (1_SUPPL): : 186 - 187
  • [33] Tau polymorphisms are not associated with Alzheimer's disease
    Kwon, JM
    Nowotny, P
    Shah, PK
    Chakraverty, S
    Norton, J
    Morris, JC
    Goate, AM
    NEUROSCIENCE LETTERS, 2000, 284 (1-2) : 77 - 80
  • [34] CSF total tau, Aβ42 and phosphorylated tau protein as biomarkers for Alzheimer’s disease
    Kaj Blennow
    Eugeen Vanmechelen
    Harald Hampel
    Molecular Neurobiology, 2001, 24 : 87 - 97
  • [35] CSF levels of tau, β-amyloid1-42 and GAP-43 in frontotemporal dementia, other types of dementia and normal aging
    Sjögren, M
    Minthon, L
    Davidsson, P
    Granérus, AK
    Clarberg, A
    Vanderstichele, H
    Vanmechelen, E
    Wallin, A
    Blennow, K
    JOURNAL OF NEURAL TRANSMISSION, 2000, 107 (05) : 563 - 579
  • [36] CSF levels of tau, β-amyloid1–42 and GAP-43 in frontotemporal dementia, other types of dementia and normal aging
    M. Sjögren
    L. Minthon
    P. Davidsson
    A. -K. Granérus
    A. Clarberg
    H. Vanderstichele
    E. Vanmechelen
    A. Wallin
    K. Blennow
    Journal of Neural Transmission, 2000, 107 : 563 - 579
  • [37] CSF total tau, aβ42 and phosphorylated tau protein as biomarkers for Alzheimer's disease
    Blennow, K
    Vanmechelen, E
    Hampel, H
    MOLECULAR NEUROBIOLOGY, 2001, 24 (1-3) : 87 - 97
  • [38] CSF p-tau205: a biomarker of tau pathology in Alzheimer's disease
    Lantero-Rodriguez, Juan
    Montoliu-Gaya, Laia
    Benedet, Andrea L.
    Vrillon, Agathe
    Dumurgier, Julien
    Cognat, Emmanuel
    Brum, Wagner S.
    Rahmouni, Nesrine
    Stevenson, Jenna
    Servaes, Stijn
    Therriault, Joseph
    Becker, Bruno
    Brinkmalm, Gunnar
    Snellman, Anniina
    Huber, Hanna
    Kvartsberg, Hlin
    Ashton, Nicholas J.
    Zetterberg, Henrik
    Paquet, Claire
    Rosa-Neto, Pedro
    Blennow, Kaj
    ACTA NEUROPATHOLOGICA, 2024, 147 (01)
  • [39] CSF markers for Alzheimer's disease:: Total Tau, phospho-tau and Aβ42
    Andreasen, N
    Sjögren, M
    Blennow, K
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2003, 4 (04): : 147 - 155
  • [40] CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer's disease
    Toledo, Jon B.
    Korff, Ane
    Shaw, Leslie M.
    Trojanowski, John Q.
    Zhang, Jing
    ACTA NEUROPATHOLOGICA, 2013, 126 (05) : 683 - 697